002210.KS | Dong Sung Bio Pharm.Co.,Ltd. Annual &

Annual Balance Sheets

(In KRW)

Breakdown	2023	2022	2021	2020	2019	2018
Total Assets	114.97 Billion	107.7 Billion	104.58 Billion	125.71 Billion	131.73 Billion	140.19 Billion
Total Current Assets	60.81 Billion	54.38 Billion	49.98 Billion	71.5 Billion	79.39 Billion	87.78 Billion
Cash And Short Term Investments	6.43 Billion	4.09 Billion	5.14 Billion	23.42 Billion	22.85 Billion	32.22 Billion
Cash and Cash Equivalents	6.43 Billion	4.09 Billion	3.14 Billion	14.35 Billion	4.27 Billion	2.21 Billion
Short Term Investments	-	-300.00	2 Billion	9.07 Billion	18.57 Billion	30.01 Billion
Net Receivables	31.29 Billion	35.36 Billion	29.32 Billion	27.8 Billion	33.26 Billion	38.2 Billion
Inventory	19.47 Billion	14.93 Billion	15.51 Billion	20.28 Billion	23.28 Billion	17.35 Billion
Other Current Assets	3.61 Billion	330.00	1070.00	200.00	700.00	350.00
Total Non-Current Assets	54.15 Billion	53.31 Billion	54.59 Billion	54.21 Billion	52.33 Billion	52.4 Billion
Net PPE	42.72 Billion	43.96 Billion	37.37 Billion	37.31 Billion	34.17 Billion	34.5 Billion
Good Will And Intangible Assets	978.8 Million	855.8 Million	942.7 Million	829.99 Million	738.79 Million	882.28 Million
Good Will	-	-	-	-	-	-
Intangible Assets	978.8 Million	855.8 Million	942.7 Million	829.99 Million	738.79 Million	882.28 Million
Long-Term Investments	7.71 Billion	510.21 Million	-1.6 Billion	-8.71 Billion	-18.21 Billion	-27.25 Billion
Tax Assets	2.00	-510.21 Million	17.88 Billion	24.78 Billion	1.15 Billion	809.3 Million
Other Non Current Assets	2.73 Billion	8.49 Billion	490.00	800.00	34.47 Billion	43.46 Billion
Other Assets	-	-	-	-	-	-10.00
Total Liabilities	75.17 Billion	64.89 Billion	58.14 Billion	70.77 Billion	61.63 Billion	82.71 Billion
Total Current Liabilities	44.84 Billion	47.57 Billion	37.58 Billion	47.83 Billion	40.54 Billion	47.13 Billion
Account Payables	11.26 Billion	8.85 Billion	6.85 Billion	9.72 Billion	9.97 Billion	10.18 Billion
Tax Payables	-	418.76 Million	262.14 Million	103.68 Million	322.62 Million	469.14 Million
Short Term Debt	24.73 Billion	29.27 Billion	19.71 Billion	14.04 Billion	15.85 Billion	20.3 Billion
Deferred Revenue	-	261.57 Million	7.28 Billion	19.49 Billion	11.11 Billion	469.14 Million
Other Current Liabilities	8.85 Billion	9.18 Billion	3.72 Billion	4.56 Billion	3.6 Billion	16.17 Billion
Total Non Current Liabilities	30.32 Billion	17.32 Billion	20.55 Billion	22.93 Billion	21.08 Billion	35.57 Billion
Long-Term Debt	18.52 Billion	7.76 Billion	9.6 Billion	12.34 Billion	11.87 Billion	22.34 Billion
Deferred Revenue Non Current	17.85 Million	-	9.11 Billion	8.38 Billion	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	8.53 Billion	7.27 Billion	440.00	260.00	9.2 Billion	13.22 Billion
Other Liabilities	1.00	-	-	-	-10.00	-
Total Equity	39.8 Billion	42.8 Billion	46.44 Billion	54.94 Billion	70.09 Billion	57.48 Billion
Stock Holders Equity	39.8 Billion	42.8 Billion	46.44 Billion	54.94 Billion	70.09 Billion	57.48 Billion
Common Stock	26.1 Billion	26.1 Billion	26.1 Billion	26.1 Billion	26.07 Billion	24.75 Billion
Retained Earnings	-3 Billion	1.15 Billion	-2.57 Billion	-10.99 Billion	-779.36 Million	7.49 Billion
Accumulated other comprehensive income	2.78 Billion	2.78 Billion	2.78 Billion	2.78 Billion	5.74 Billion	5.74 Billion
Common Stock Equity	39.8 Billion	42.8 Billion	46.44 Billion	54.94 Billion	70.09 Billion	57.48 Billion
Capital Lease Obligation	17.85 Million	104.13 Million	55.66 Million	70.14 Million	78.05 Million	-
Total Investments	7.71 Billion	510.21 Million	395.66 Million	353.78 Million	365.09 Million	2.75 Billion
Total Debt	43.27 Billion	37.03 Billion	29.31 Billion	26.39 Billion	27.72 Billion	42.65 Billion
Net Debt	36.83 Billion	32.94 Billion	26.17 Billion	12.04 Billion	23.44 Billion	40.44 Billion

Breakdown	2024 Q2	2024 Q1	2023 Q4	2023 FY	2023 Q3	2023 Q2
Total Assets	122.76 Billion	118.14 Billion	114.97 Billion	114.97 Billion	120.2 Billion	112.64 Billion
Total Current Assets	69.3 Billion	64.46 Billion	60.81 Billion	60.81 Billion	65.67 Billion	57.87 Billion
Cash And Short Term Investments	2.78 Billion	1.97 Billion	6.43 Billion	6.43 Billion	8.64 Billion	4.49 Billion
Cash and Cash Equivalents	2.78 Billion	1.97 Billion	6.43 Billion	6.43 Billion	6.66 Billion	2.37 Billion
Short Term Investments	-	-	-	-	1.97 Billion	2.11 Billion
Net Receivables	33.82 Billion	32.61 Billion	31.29 Billion	31.29 Billion	32.09 Billion	31.65 Billion
Inventory	21.06 Billion	20.02 Billion	19.47 Billion	19.47 Billion	19.07 Billion	17.63 Billion
Other Current Assets	11.63 Billion	9.84 Billion	3.61 Billion	3.61 Billion	5.85 Billion	4.09 Billion
Total Non-Current Assets	53.46 Billion	53.68 Billion	54.15 Billion	54.15 Billion	54.52 Billion	54.76 Billion
Net PPE	42.74 Billion	42.8 Billion	42.72 Billion	42.72 Billion	42.98 Billion	43.31 Billion
Good Will And Intangible Assets	857.33 Million	917.48 Million	978.8 Million	978.8 Million	1.01 Billion	830.5 Million
Good Will	-	-	-	-	-	-
Intangible Assets	857.33 Million	917.48 Million	978.8 Million	978.8 Million	1.01 Billion	830.5 Million
Long-Term Investments	7.29 Billion	7.31 Billion	7.71 Billion	7.71 Billion	-1.36 Billion	-1.52 Billion
Tax Assets	-857.33 Million	-917.48 Million	2.00	2.00	9.3 Billion	9.46 Billion
Other Non Current Assets	3.42 Billion	3.56 Billion	2.73 Billion	2.73 Billion	2.59 Billion	2.66 Billion
Other Assets	-	-	-	-	-1000.00	-
Total Liabilities	85.01 Billion	78.58 Billion	75.17 Billion	75.17 Billion	78.48 Billion	70.85 Billion
Total Current Liabilities	71.07 Billion	49.79 Billion	44.84 Billion	44.84 Billion	49.3 Billion	51.94 Billion
Account Payables	12.07 Billion	11.06 Billion	11.26 Billion	11.26 Billion	13.72 Billion	12.78 Billion
Tax Payables	-	-	-	-	-	-
Short Term Debt	51.84 Billion	29.95 Billion	24.73 Billion	24.73 Billion	26.79 Billion	31.69 Billion
Deferred Revenue	-	-	-	-	-13.72 Billion	-12.78 Billion
Other Current Liabilities	7.15 Billion	8.76 Billion	8.85 Billion	8.85 Billion	22.51 Billion	20.24 Billion
Total Non Current Liabilities	13.94 Billion	28.79 Billion	30.32 Billion	30.32 Billion	29.18 Billion	18.9 Billion
Long-Term Debt	828 Million	16.94 Billion	18.52 Billion	18.52 Billion	18.51 Billion	7.46 Billion
Deferred Revenue Non Current	4.14 Million	11.04 Million	17.85 Million	17.85 Million	8.66 Billion	8.48 Billion
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	9.9 Billion	8.65 Billion	8.53 Billion	8.53 Billion	-320.00	-10.00
Other Liabilities	1.00	-	1.00	1.00	-	10.00
Total Equity	37.75 Billion	39.55 Billion	39.8 Billion	39.8 Billion	41.71 Billion	41.79 Billion
Stock Holders Equity	37.75 Billion	39.55 Billion	39.8 Billion	39.8 Billion	41.71 Billion	41.79 Billion
Common Stock	26.1 Billion	26.1 Billion	26.1 Billion	26.1 Billion	26.1 Billion	26.1 Billion
Retained Earnings	-2.05 Billion	-248.71 Million	-3 Billion	-3 Billion	1.69 Billion	1.76 Billion
Accumulated other comprehensive income	2.78 Billion	2.78 Billion	2.78 Billion	2.78 Billion	2.78 Billion	2.78 Billion
Common Stock Equity	37.75 Billion	39.55 Billion	39.8 Billion	39.8 Billion	41.71 Billion	41.79 Billion
Capital Lease Obligation	4.14 Million	11.04 Million	17.85 Million	17.85 Million	73.38 Million	61.51 Million
Total Investments	7.29 Billion	7.31 Billion	7.71 Billion	7.71 Billion	610.45 Million	595.19 Million
Total Debt	52.67 Billion	46.91 Billion	43.27 Billion	43.27 Billion	45.3 Billion	39.16 Billion
Net Debt	49.89 Billion	44.93 Billion	36.83 Billion	36.83 Billion	38.64 Billion	36.78 Billion

Balance Sheet Charts

Lotte Shopping Co., Ltd.

023530

Full Analysis

Annual Balance Sheets
KEL Corporation

6919

Full Analysis

Annual Balance Sheets
QMC Quantum Minerals Corp

QMCQF

Full Analysis

Annual Balance Sheets
Hitachi, Ltd.

HTHIF

Full Analysis

Annual Balance Sheets
Tsubota Laboratory Incorporated

4890

Full Analysis

Annual Balance Sheets
Eugene Corporation

023410

Full Analysis

Annual Balance Sheets

Global Stocks Search

Dong Sung Bio Pharm.Co.,Ltd. (002210.KS)

Annual Balance Sheets

Balance Sheet Charts

Lotte Shopping Co., Ltd.

KEL Corporation

QMC Quantum Minerals Corp

Hitachi, Ltd.

Tsubota Laboratory Incorporated

Eugene Corporation